SciSparc : MitoCareX Update - Form 6-K -March 13, 2024 at 09:09 am EDT
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer ...
Source: marketscreener.com
Alon Silberman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alon Silberman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alon Silberman Today - Breaking & Trending Today
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure -March 12, 2024 at 08:15 am EDT
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 -- SciSparc Ltd. , a specialty clinical-stage...
Source: marketscreener.com
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that MitoCareX Bio Ltd. ("MitoCareX "), the Company’s venture with Dr. Alon Silberman that focuses on drug discovery and the
Source: yahoo.com
SciSparc: MitoCareX Reveals Promising Results with
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 12, 2024 (GLOBE...
Source: globenewswire.com
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
MitoCareX Bio met its second milestone as part of its joint venture agreement with the Company TEL AVIV, Israel, Dec. 13, 2023 -- SciSparc Ltd. , a specialty clinical-stage pharmaceutical...
Source: marketscreener.com